Table 3 Adequacy and results of HPV and cytological analyses.
Variables | Conventional samples | Samples in liquid medium | Dry samples | |||
|---|---|---|---|---|---|---|
Viba-Brush® | Mía by Xytotest® | Iune | Viscose | |||
HPV test results n (%) | n = 120 | n = 59 | n = 59 | n = 61 | n = 61 | |
Negative | 75 (62.5%) | 33 (55.9%) | 34 (57.6%) | 35 (57.4%) | 38 (62.3%) | |
Type 16 ± other types | 11 (9.2%) | 9 (15.3%) | 8 (13.6%) | 7 (11.5%) | 6 (9.8%) | |
Type 18 ± other types | 4 (3.3%) | 2 (3.4%) | 2 (3.4%) | 3 (4.9%) | 3 (4.9%) | |
Only other types | 30 (25.0%) | 15 (25.4%) | 15 (25.4%) | 16 (26.2%) | 14 (23.0%) | |
Specimen adequacy n (%) | n = 120 | n = 59 | n = 59 | |||
Unsatisfactory | 24 (20.0%) | 1 (1.7%) | 1 (1.7%) | |||
Satisfactory | ||||||
Without endocervical component | 29 (24.2%) | 43 (72.9%) | 45 (76.3%) | |||
With endocervical component | 67 (55.8%) | 15 (25.4%) | 13 (22.0%) | |||
Cytological results n (%) | n = 96 | n = 58 | n = 58 | |||
Negative | 57 (59.4%) | 38 (65.5%) | 41 (70.7%) | |||
ASC-US and LSIL | 32 (33.3%) | 19 (32.8%) | 14 (24.1%) | |||
ASC-H. AIS and HSIL | 7 (7.3%) | 1 (1.7%) | 3 (5.2%) | |||
